Skip to main content
OpenTrials

Clinical trial condition

Advanced Melanoma

Explore clinical trials studying Advanced Melanoma. Study availability and eligibility vary by location and protocol.

67 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Advanced Melanoma trial results

Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

NCT02965716

Conditions
Advanced Melanoma, Melanoma, Neoplasms, +17 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

NCT05529316

Conditions
Advanced Melanoma
Locations
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • Virginia K. Crosson Cancer Center at St. Jude Medical Center Fullerton, California, United States
  • Providence Saint John's Health Center Santa Monica, California, United States
  • Yale University School of Medicine - Yale Cancer Center New Haven, Connecticut, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

NCT06112808

Conditions
Advanced Melanoma
Locations
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Republic Scientific and Practical Centre for Oncology and Medical Radiology Named after N.N.Aleksandrov" Minsk, Belarus
  • Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine Chelyabinsk, Chelyabinsk Oblast, Russia
  • JSC "Modern Medical Technologies" Saint Petersburg, Sankt-Peterburg, Russia
View all 30 locations
View Trial Details
Active, Not Recruiting

Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

NCT06640530

Conditions
Advanced Melanoma, Melanoma, Melanoma (Skin), +11 more
Locations
  • Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus
  • Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Republic Scientific and Practical Centre for Oncology and Medical Radiology Named after N.N.Aleksandrov" Minsk, Belarus
View all 44 locations
View Trial Details
Active, Not Recruiting

Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma

NCT04951583

Conditions
Advanced Melanoma, Non Small Cell Lung Cancer Metastatic
Locations
  • London Health Sciences Centre London, Ontario, Canada
  • DRCC Lakeridge Health Oshawa, Ontario, Canada
  • Sunnybrook Health Sciences Centre/Sunnybrook Research Institute Toronto, Ontario, Canada
  • Centre hospitalier de l'Université de Montréal (CHUM) Montreal, Quebec, Canada
View Trial Details

Related conditions